Sensyne Health plc is a health information services business based in the UK. Sensyne Health shares (SENS.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 117.5p – a decrease of 20.88% over the previous week. Sensyne Health employs 135 staff and has a trailing 12-month revenue of around £2.1 million.
Since the stock market crash in March caused by coronavirus, Sensyne Health's share price has had significant positive movement.
Its last market close was 117.5p, which is 59.57% up on its pre-crash value of 47.5p and 209.21% up on the lowest point reached during the March crash when the shares fell as low as 38p.
If you had bought £1,000 worth of Sensyne Health shares at the start of February 2020, those shares would have been worth £675.21 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £2,008.55.
|Latest market close||117.5p|
|52-week range||28.0001p - 153.0833p|
|50-day moving average||129.7353p|
|200-day moving average||77.5204p|
|Wall St. target price||261p|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||-18.5p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-07)||8.33%|
|1 month (2020-12-15)||8.33%|
|3 months (2020-10-16)||49.43%|
|6 months (2020-07-14)||319.35%|
|1 year (2020-01-14)||130.09%|
|2 years (2019-01-14)||-17.36%|
|Revenue TTM||£2.1 million|
|Gross profit TTM||£1.2 million|
|Return on assets TTM||-21.08%|
|Return on equity TTM||-39.97%|
|Market capitalisation||£148.6 million|
TTM: trailing 12 months
We're not expecting Sensyne Health to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Sensyne Health's shares have ranged in value from as little as 28.0001p up to 153.0833p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Sensyne Health's is 0.564. This would suggest that Sensyne Health's shares are less volatile than average (for this exchange).
Sensyne Health plc, a healthcare technology company, develops software products that connects healthcare professionals with patients in the United Kingdom and the United States. Its products include CVm-Health, a web-based application for coronavirus self-monitoring; DBm-Health, which helps individuals monitor their blood glucose levels and share their readings with health care professionals; GDm-Health, a prescribed digital therapeutic for remote management of diabetes in pregnancy; and BPm-Health that allows pregnant women to self-monitor blood pressure during pregnancy. The company's products also include SEND, an early warning system for monitoring patient vital signs in hospital; EDGE, a prescribed digital therapeutic for monitoring chronic obstructive pulmonary disease at home; CleanSpace, a system for monitoring personal exposure to air pollution; and Support-HF, a prescribed digital therapeutic for monitoring heart failure at home. Sensyne Health has strategic research alliance with Bayer to develop new treatments using clinical artificial intelligence; research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Milton Keynes University Hospital NHS Foundation Trust to enable the ethical application of clinical artificial intelligence research to improve patient care and research into new medicines; collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Hampshire Hospitals NHS Foundation Trust. Sensyne Health plc was incorporated in 2018 and is based in Oxford, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.